Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells
Tu, C., Du, Z., Zhang, H. et al. Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells. Theranostics. (2021). https://www.thno.org/v11p2364.htm
Read more
LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer
Hu, Z., Zheng, X., Jiao, D. et al. LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer. Mol Ther Oncolytics. (2020). https://doi.org/10.1016/j.omto.2020.04.008
Read more
IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
Chen, T., Ding, X., Liao, Q. et al. IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy. J Immunother Cancer. (2021). http://dx.doi.org/10.1136/jitc-2020-001647
Read more
Long-Term Engraftment Promotes Differentiation of Alveolar Epithelial Cells from Human Embryonic Stem Cell Derived Lung Organoids
Chen, Y., Feng, J., Zhao, S. et al. Long-Term Engraftment Promotes Differentiation of Alveolar Epithelial Cells from Human Embryonic Stem Cell Derived Lung Organoids. Stem Cells Dev. (2018). https://doi.org/10.1038/s41408-021-00502-7
Read more
PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity
Jiang, H., Ni, H., Zhang, P. et al. PD-L1/LAG3 bispecific antibody enhances tumor-specific immunity. Oncoimmunology. (2021). https://doi.org/10.1080/2162402X.2021.1943180
Read more
Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer
Zhai, T., Wang, C., Xu, Y. et al. Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer. J Immunother Cancer. (2021). http://dx.doi.org/10.1136/jitc-2020-002131
Read more
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade
Jeong, S., Park, E., Kim, H-D. et al. Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade. J Immunother Cancer. (2021). http://dx.doi.org/10.1136/jitc-2021-002428
Read more
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Damelin, M., Bankovich, A., Bernstein, J. et al. A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions. Sci. Transl. Med. (2017). https://www.science.org/doi/10.1126/scitranslmed.aag2611
Read more
IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis
Li, L., Wu, Z., Wu, M. et al. IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis. Int. Immunopharmacol. (2020). https://doi.org/10.1016/j.intimp.2020.107008
Read more
Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer
Li, Y., Fengjun, X., Zhang, D. et al. Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer. Cell Immunol. (2020). https://doi.org/10.1016/j.cellimm.2020.104041
Read more